<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="brief-report" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Cardiovasc Med</journal-id><journal-id journal-id-type="iso-abbrev">Front Cardiovasc Med</journal-id><journal-id journal-id-type="pmc-domain-id">2863</journal-id><journal-id journal-id-type="pmc-domain">fcvm</journal-id><journal-id journal-id-type="publisher-id">Front. Cardiovasc. Med.</journal-id><journal-title-group><journal-title>Frontiers in Cardiovascular Medicine</journal-title></journal-title-group><issn pub-type="epub">2297-055X</issn><publisher><publisher-name>Frontiers Media SA</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10050368</article-id><article-id pub-id-type="pmcid-ver">PMC10050368.1</article-id><article-id pub-id-type="pmcaid">10050368</article-id><article-id pub-id-type="pmcaiid">10050368</article-id><article-id pub-id-type="pmid">37008329</article-id><article-id pub-id-type="doi">10.3389/fcvm.2023.1092555</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Cardiovascular Medicine</subject><subj-group><subject>Brief Research Report</subject></subj-group></subj-group></article-categories><title-group><article-title>Genetic deficiency of protein inhibitor of activated STAT3 suppresses experimental abdominal aortic aneurysms</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Fu</surname><given-names initials="W">Weilai</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="an" ref-type="author-notes">
<sup>&#8224;</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names initials="H">Haole</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="an" ref-type="author-notes">
<sup>&#8224;</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/2168363/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wei</surname><given-names initials="P">Panpan</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Xia</surname><given-names initials="C">Congcong</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yu</surname><given-names initials="Q">Qingqing</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tian</surname><given-names initials="K">Kangli</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="Y">Yankui</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names initials="E">Enqi</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/1176113/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Xu</surname><given-names initials="B">Baohui</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/1322780/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Miyata</surname><given-names initials="M">Masaaki</given-names></name><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/1442134/overview"/></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Wang</surname><given-names initials="R">Rong</given-names></name><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/1001357/overview"/><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Zhao</surname><given-names initials="S">Sihai</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="cor1" ref-type="corresp">*</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/1509146/overview"/></contrib></contrib-group><aff id="aff1"><label><sup>1</sup></label><addr-line>Institute of Cardiovascular Science, Translational Medicine Institute</addr-line>, <institution>Xi'an Jiaotong University Health Science Center</institution>, <addr-line>Xi&#8217;an</addr-line>, <country>China</country></aff><aff id="aff2"><label><sup>2</sup></label><addr-line>Department of Vascular Surgery</addr-line>, <institution>The Second Hospital of Tianjin Medical University</institution>, <addr-line>Tianjin</addr-line>, <country>China</country></aff><aff id="aff3"><label><sup>3</sup></label><addr-line>Laboratory Animal Center</addr-line>, <institution>Xi'an Jiaotong University Health Science Center</institution>, <addr-line>Xi&#8217;an</addr-line>, <country>China</country></aff><aff id="aff4"><label><sup>4</sup></label><addr-line>Department of Surgery</addr-line>, <institution>Stanford University School of Medicine</institution>, <addr-line>Stanford, CA</addr-line>, <country>United States</country></aff><aff id="aff5"><label><sup>5</sup></label><addr-line>School of Health Science, Faculty of Medicine</addr-line>, <institution>Kagoshima University</institution>, <addr-line>Kagoshima</addr-line>, <country>Japan</country></aff><author-notes><fn fn-type="edited-by"><p><bold>Edited by:</bold> Hiroki Aoki, Kurume University, Japan</p></fn><fn fn-type="edited-by"><p><bold>Reviewed by:</bold> Venkateswaran Subramanian, University of Missouri, United States Xiangqian Kong, Shandong Provincial Hospital, China</p></fn><corresp id="cor1"><label>*</label><bold>Correspondence:</bold> Rong Wang <email>rongw1986@xjtu.edu.cn</email> Sihai Zhao <email>sihaizhao@xjtu.edu.cn</email></corresp><fn fn-type="other" id="an"><label>
<sup>&#8224;</sup>
</label><p>These authors share first authorship</p></fn><fn fn-type="other" id="fn001"><p><bold>Specialty Section:</bold> This article was submitted to Atherosclerosis and Vascular Medicine, a section of the journal Frontiers in Cardiovascular Medicine</p></fn></author-notes><pub-date pub-type="epub"><day>15</day><month>3</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>10</volume><issue-id pub-id-type="pmc-issue-id">427754</issue-id><elocation-id>1092555</elocation-id><history><date date-type="received"><day>01</day><month>12</month><year>2022</year></date><date date-type="accepted"><day>27</day><month>2</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>01</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>30</day><month>03</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-05-11 03:25:13.993"><day>11</day><month>05</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; 2023 Fu, Liu, Wei, Xia, Yu, Tian, Li, Liu, Xu, Miyata, Wang and Zhao.</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Fu, Liu, Wei, Xia, Yu, Tian, Li, Liu, Xu, Miyata, Wang and Zhao</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="fcvm-10-1092555.pdf"/><abstract><sec><title>Aim</title><p>Signal transducer and activator of transcription (STAT) signaling is critical for the pathogenesis of abdominal aortic aneurysms (AAAs). Though protein inhibitor of activated STAT3 (PIAS3) negatively modulates STAT3 activity, but its role in AAA disease remains undefined.</p></sec><sec><title>Method</title><p>AAAs were induced in PIAS3 deficient (PIAS3<sup>&#8722;/&#8722;</sup>) and wild type (PIAS3<sup>+/+</sup>) male mice <italic toggle="yes">via</italic> transient intra-aortic elastase infusion. AAAs were assessed by <italic toggle="yes">in situ</italic> measurements of infrarenal aortic external diameters prior to (day 0) and 14 days after elastase infusion. Characteristic aneurysmal pathologies were evaluated by histopathology.</p></sec><sec><title>Results</title><p>Fourteen days following elastase infusion, aneurysmal aortic diameter was reduced by an approximately 50% in PIAS3<sup>&#8722;/&#8722;</sup> as compared to PIAS3<sup>+/+</sup> mice. On histological analyses, PIAS3<sup>&#8722;/&#8722;</sup> mice showed less medial elastin degradation (media score: 2.5) and smooth muscle cell loss (media score: 3.0) than those in PIAS3<sup>+/+</sup> mice (media score: 4 for both elastin and SMC destruction). Aortic wall leukocyte accumulation including macrophages, CD4<sup>+</sup> T cells, CD8<sup>+</sup> T cells and B cells as well as mural neovessel formation were significantly reduced in PIAS3<sup>&#8722;/&#8722;</sup> as compared to PIAS3<sup>+/+</sup> mice. Additionally, PIAS3 deficiency also downregulated the expression levels of matrix metalloproteinases 2 and 9 by 61% and 70%, respectively, in aneurysmal lesion.</p></sec><sec><title>Conclusion</title><p>PIAS3 deficiency ameliorated experimental AAAs in conjunction with reduced medial elastin degradation and smooth muscle cell depletion, mural leukocyte accumulation and angiogenesis.</p></sec></abstract><kwd-group><kwd>abdominal aortic aneurysm</kwd><kwd>protein inhibitor of activated STAT3</kwd><kwd>inflammation</kwd><kwd>macrophage</kwd><kwd>animal model</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">Natural Science Foundation of Shaanxi Province</funding-source><award-id award-type="contract" rid="cn001">2023-CX-PT-17, 2021PT-056, 2023-CX-PT-01</award-id></award-group><award-group><funding-source id="cn002">Natural Science Project of Xi&#8217;an Jiaotong University</funding-source><award-id award-type="contract" rid="cn002">YXJLRH2022073</award-id></award-group><award-group><funding-source id="cn003">National Natural Science Foundation of China</funding-source><award-id award-type="contract" rid="cn003">82170471</award-id></award-group></funding-group><funding-group><funding-statement>This work was partly supported by grants from the Natural Science Foundation of Shaanxi Province (2023-CX-PT-17, 2021PT-056, 2023-CX-PT-01), Natural Science Project of Xi&#8217;an Jiaotong University (YXJLRH2022073) and the National Natural Science Foundation of China (82170471).</funding-statement></funding-group><counts><fig-count count="4"/><table-count count="0"/><equation-count count="0"/><ref-count count="43"/><page-count count="0"/><word-count count="0"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Abdominal aortic aneurysm (AAA) is a lethal degenerative disease that is prevalent in older smoker men (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>). Inflammation is one of well-established pathophysiological mechanisms in the genesis of AAAs. For example, the circulating levels of inflammatory cytokines such as interleukin (IL)-6, IL-1&#946;, tumor necrosis factor (TNF)-<italic toggle="yes">&#945;</italic> and other mediators were elevated in patients with AAAs and may mediate AAA formation and progression (<xref rid="B3" ref-type="bibr">3</xref>&#8211;<xref rid="B5" ref-type="bibr">5</xref>). Inhibition of inflammatory cytokines effectively attenuated experimental AAA formation (<xref rid="B6" ref-type="bibr">6</xref>&#8211;<xref rid="B8" ref-type="bibr">8</xref>).</p><p>Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling critically regulates inflammatory responses (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B10" ref-type="bibr">10</xref>). It is involved in cytokine production, immune cell recruitment, and initiation of adaptive responses (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B11" ref-type="bibr">11</xref>). Four JAKs (JAK1-JAK3 and tyrosine kinase 2) and seven STATs (STAT1-STAT4, STAT5a, STAT5b, and STAT6) are present in mammalian cells (<xref rid="B12" ref-type="bibr">12</xref>). JAK2/STAT3 signaling modulates cell proliferation as well as cell survival. Additionally, enhanced JAK2/STAT3 signaling activity has been reported in clinical AAA specimens (<xref rid="B13" ref-type="bibr">13</xref>).</p><p>Excessively activating JAK/STAT signaling leads to dysregulated immune responses and thus tissue damage. Several endogenous inhibitory proteins, such as protein inhibitor of activated STAT (PIAS) and suppressor of cytokine signaling (SOCS), are evolved to limit overwhelming inflammation due to augmented JAK/STAT activity. We previously showed that PIAS3 was reversely associated with atherosclerotic progression and inhibited inflammatory responses and smooth muscle cell (SMC) proliferation (<xref rid="B14" ref-type="bibr">14</xref>). AAA as a chronic inflammatory disease may share some common pathogenic pathways with atherosclerosis. The role PIAS3 plays in AAAs has not been clarified. Therefore, the present study was to investigate the influence of PIAS3 deficiency on experimental AAAs in the elastase-induced AAA model.</p></sec><sec id="s2"><title>Materials and methods</title><sec id="s2a"><title>Animals</title><p>PIAS3 gene (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="NM_001165949">NM_001165949</ext-link>) is located on mouse chromosome 3 with fourteen exons (<xref rid="B15" ref-type="bibr">15</xref>). PIAS3 deficient (PIAS3<sup>&#8722;/&#8722;</sup>) mice on C57BL/6 genetic background were created in Cyagen Biosciences (Suzhou) Inc (Taicang, Jiangsu, China) using the CRISPR/CAS9 technique. Briefly, the exons of 2&#8211;9 were selected as target sites, and two gRNAs with Cas9 mRNA were microinjected into zygotes for PIAS3 deficient mouse generation (<xref rid="F1" ref-type="fig">Figure&#160;1A</xref>). F0 founders were identified <italic toggle="yes">via</italic> PCR genotyping followed by DNA sequencing. Homozygotes (PIAS3<sup>&#8722;/&#8722;</sup>) and wild type (PIAS3<sup>+/+</sup>) littermates were screened and used for all experiments. The use and care of animals as well as all experimental procedures were reviewed and approved by the Laboratory Animal Administration Committee of Xi'an Jiaotong University (No. 2019&#8211;1178). All information on animals and related reagents were detailed in <xref rid="s10" ref-type="sec">Supplementary Table S1</xref>.</p></sec><sec id="s2b"><title>Phenotyping of PIAS3 deficient mice</title><p>For PCR screening, tail tip samples were collected from &lt;3 weeks old mice and genomic DNA was extracted by proteinase K digestion. Genotyping PCR primers were AAACAAGACTAAAGGAGTATGGGC (sense 1), TAGAGGAAGGGGAAGGGAACTAAG (antisense 1) and CTCAGACACTCGGAAACTCATC (antisense 2). For quantitative reverse transcription PCR (qRT-PCR) and Western blotting analyses, total RNA and proteins were extracted from aortas. The PIAS3 primers for qRT-PCR analysis were sense: ACCAAGAATGGAGCTGAGCC (sense) and TCTGGATTCCGGATCCCCTT (antisense). Antibodies against PIAS3 and <italic toggle="yes">&#946;</italic>-actin were obtained from Cell Signaling Technology (Danvers, MA, United States) and TransGen Biotech Co., Ltd (Beijing, China), respectively.</p></sec><sec id="s2c"><title>Experimental AAA modeling</title><p>Experimental AAAs were induced in PIAS3<sup>&#8722;/&#8722;</sup> and PIAS3<sup>+/+</sup> mice by transient luminal infusion of porcine pancreatic elastase (PPE, 1.5 units/mL in phosphate-buffered saline) in controlled infrarenal aortic segment as previously reported (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B17" ref-type="bibr">17</xref>). Briefly, 9&#8211;12 weeks old male mice were anesthetized by 2% isoflurane inhalation, and infrarenal aorta was exposed <italic toggle="yes">via</italic> a laparotomy. Infrarenal aorta was then infused with PPE solution <italic toggle="yes">via</italic> an aortotomy for 5&#8197;min under constant pressure as previously described (<xref rid="B18" ref-type="bibr">18</xref>). After the surgery, all mice were maintained in individual cages with free access to chow diet and water.</p></sec><sec id="s2d"><title>Measurement of abdominal aortic diameters</title><p>Prior to PPE infusion, infrarenal aorta was photographed with a digital camera. The diameter was measured using Images Plus3.0 ML (Motic Electric Group Co., Ltd, Xiamen, Fujian, China) and served the baseline level. On day 14 after PPE infusion, infrarenal aortic diameter for each mouse was measured by the same procedure prior to sacrifice and aorta was then harvested. A mouse with a more than 50% aortic dilation over the baseline was considered aneurysmal (<xref rid="B18" ref-type="bibr">18</xref>).</p></sec><sec id="s2e"><title>Analysis of medial elastin and SMCs</title><p>Mice were euthanized by carbon dioxide inhalation. PPE-infused aortic segment was collected, embedded in optimal cutting temperature media, and sectioned (6&#8197;&#956;m). Frozen sections were stained with hematoxylin and eosin (H &amp; E) and Elastic van Gieson (EVG) stains, respectively, for the assessment of general morphology and elastin integrity. Aortic media elastin degradation was graded as I (mild) to IV (severe) on EVG-stained sections as previously reported (<xref rid="B16" ref-type="bibr">16</xref>&#8211;<xref rid="B20" ref-type="bibr">20</xref>). To evaluate SMC depletion, acetone-fixed frozen sections were stained with a goat anti-SMC <italic toggle="yes">&#945;</italic>-actin antibody followed a standard biotin-streptavidin peroxidase procedure. Biotinylated donkey anti-goat IgG antibody and streptavidin-peroxidase conjugate were obtained from the Jackson ImmunoResearch Laboratories Inc., West Glove, PA, United States). AEC substrate kit for color development was purchased from Vector Laboratories Inc., Burlingame, CA, United States. Aortic medial SMC depletion was graded on a scale of I (mild) to IV (severe) as reported previously (<xref rid="B20" ref-type="bibr">20</xref>).</p></sec><sec id="s2f"><title>Analysis of aortic leukocytes</title><p>Acetone-fixed aortic frozen sections were stained with monoclonal antibodies against CD68 (macrophages), CD4<sup>+</sup> T cells, CD8<sup>+</sup> T cells and B cells (B220) (<xref rid="B18" ref-type="bibr">18</xref>). Sections were sequentially incubated with biotinylated goat anti-rat antibody (Vector Laboratories Inc), PBS, streptavidin-peroxidase conjugate (Jackson ImmunoResearch Laboratories Inc), PBS, peroxidase substrate AEC (Vector Laboratories Inc), counterstained with hematoxylin, mounted and cover-slipped. Aortic mural macrophage accumulation was graded on a scale of I (mild) to IV (severe) (<xref rid="B20" ref-type="bibr">20</xref>). CD4<sup>+</sup> T cells, CD8<sup>+</sup> T cells and B cells were quantitated as positively stained cells per aortic cross section (ACS) (<xref rid="B20" ref-type="bibr">20</xref>).</p></sec><sec id="s2g"><title>Immunostaining of aneurysmal matrix metalloproteinases</title><p>Matrix metalloproteinases (MMPs), particularly MMP2 and MMP9, contribute to the pathogenesis of AAAs. MMP2 and MMP9 were assessed by immunostaining using goat anti-mouse polyclonal antibodies against MMP2 (AF1488) and MMP9 (AF909) (R &amp; D Systems, Minneapolis, MN, United States) (Cite your JIR article). The expression levels were quantitated as the positively stained area per ACS using the image analysis software (WinRoof 6.5, Mitani Co. Ltd., Tokyo, Japan).</p></sec><sec id="s2h"><title>Analysis of mural angiogenesis</title><p>Angiogenesis was analyzed by immunostaining with rat anti-mouse CD31 monoclonal antibody (Clone 390, Biolegend Inc, San Diego, CA, United States) previously described. The neovessels number were counted under the microscope and reported as CD31-positive vessels per ACS (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B21" ref-type="bibr">21</xref>).</p></sec><sec id="s2i"><title>Statistical analysis</title><p>Prism 9.0 software was used for all statistical analyses. Continuous variables were expressed as mean and standard deviation (normal distribution) or media with interquartile (not normal distribution). Student's <italic toggle="yes">t</italic> and nonparametric Mann-Whitney tests were used for normally and nonnormally distributed data, respectively. Two-way ANOVA followed by Sidak's multiple comparisons test was used for testing statistical difference for aortic diameters among groups. Statistical significance level was set at <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05.</p></sec></sec><sec sec-type="results" id="s3"><title>Results</title><sec id="s3a"><title>Generation of PIAS3 knockout mice</title><p>As illustrated in <xref rid="F1" ref-type="fig">Figures&#160;1A,B</xref>, PIAS3 deficient mice were successfully generated by CRISPR/Cas9 techniques. PCR genotyping demonstrated the homozygotes of PIAS3 deficiency. qRT-PCR and Western blotting analysis further confirmed the deficiency of PIAS3 at mRNA and protein levels in PIAS3<sup>&#8722;/&#8722;</sup> as compared to PIAS3<sup>+/+</sup> mice.</p><fig position="float" id="F1" orientation="portrait"><label>Figure 1</label><caption><p>Genetic deficiency of PIAS3 suppresses experimental AAAs. (<bold>A</bold>): Strategy for generating PIAS3 deficient (PIAS3<sup>&#8722;/&#8722;</sup>) mice by targeting exons 2-9 <italic toggle="yes">via</italic> the CRISPR/Cas9 technique. (<bold>B</bold>): Characterization of PIAS3<sup>&#8722;/&#8722;</sup> mice by PCR genotyping, qRT-PCR and Western blotting analyses. <bold>(C</bold>): Representative aortic photographs and quantification of aortic diameters on day 0 and day 14 after elastase infusion. Dotted line indicates average aortic diameter after PBS infusion (approximately 0.8&#8197;mm). (<bold>D</bold>): Representative images of H&amp;E, EVG and SMC <italic toggle="yes">&#945;</italic>-actin staining as well as the semi-quantification (media and interquartile) of aneurysmal medial elastin and SMC destruction. Two-way ANOVA followed two group comparison (<bold>C</bold>) and non-parametric Mann-Whitney test (<bold>D</bold>). <italic toggle="yes">N</italic>&#8201;=&#8201;10 for each group, *<italic toggle="yes">p&#8201;</italic>&lt;&#8201;0.05 and **<italic toggle="yes">p&#8201;</italic>&lt;&#8201;0.01 as compared to PIAS3<sup>+/+</sup> mice.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fcvm-10-1092555-g001.jpg"/></fig></sec><sec id="s3b"><title>PIAS3 deficiency suppresses PPE-induced aortic dilation in mice</title><p>Intra-infrarenal aortic PPE infusion was conducted to induce AAAs in PIAS3<sup>+/+</sup> and PIAS3<sup>&#8722;/&#8722;</sup> mice. Experimental AAAs were successfully induced in PIAS3<sup>+/+</sup> mice (<xref rid="F1" ref-type="fig">Figure&#160;1C</xref>). PIAS3 deficiency significantly inhibited aortic expansion as compared to PIAS3<sup>+/+</sup> mice. Aortic diameter on day 14 after PPE infusion were 1.03&#8201;&#177;&#8201;0.07&#8197;mm and 1.26&#8201;&#177;&#8201;0.10&#8197;mm for PIAS3<sup>&#8722;/&#8722;</sup> and PIAS3<sup>+/+</sup> mice, respectively (<xref rid="F1" ref-type="fig">Figure&#160;1C</xref>). After subtracting an average aortic dilation caused by PBS infusion (approximately 0.8&#8197;mm), PIAS3 deficiency reduced PPE-induced aortic expansion by approximately 50% (<xref rid="F1" ref-type="fig">Figure&#160;1C</xref>, middle panel). The diameter increase over the baseline was significantly less in PIAS3<sup>&#8722;/&#8722;</sup> than that in PIAS3<sup>+/+</sup> mice (<xref rid="F1" ref-type="fig">Figure&#160;1C</xref>, right panel).</p></sec><sec id="s3c"><title>PIAS3 deficiency ameliorates medial elastin degradation and SMC depletion</title><p>Histological analysis was performed in aneurysmal aortas. In H&amp;E staining, PPE infusion induced a remarkable aortic dilation, predominant inflammatory cell infiltration, medial elastin degradation and SMC loss (<xref rid="F1" ref-type="fig">Figure&#160;1D</xref>, left panel). However, PIAS3<sup>&#8722;/&#8722;</sup> mice were protective against the destruction of medial elastin and SMCs. In comparison with PIAS3<sup>+/+</sup> mice, the integrity of medial elastin was relatively preserved in PIAS3<sup>&#8722;/&#8722;</sup> mice, with significantly reduced elastin degradation score (<xref rid="F1" ref-type="fig">Figure&#160;1D</xref>, middle panel). Similar was true for medial SMCs (<xref rid="F1" ref-type="fig">Figure&#160;1D</xref>, right panel).</p></sec><sec id="s3d"><title>PIAS3 deficiency inhibits aortic leukocyte accumulation</title><p>In aortic immunostaining, the score for the accumulation of macrophages, identified by CD68-positve cells, was significantly lower in PIAS3<sup>&#8722;/&#8722;</sup> than that in PIAS3<sup>+/+</sup> mice (<xref rid="F2" ref-type="fig">Figures&#160;2A,B</xref>). Similarly, PIAS3 deficiency reduced the accumulation of CD4<sup>+</sup> T cells, CD8<sup>+</sup> T cells and B cells by approximately 50% (<xref rid="F2" ref-type="fig">Figure&#160;2</xref>).</p><fig position="float" id="F2" orientation="portrait"><label>Figure 2</label><caption><p>PIAS3 deficiency inhibits aneurysmal aortic leukocyte accumulation. (<bold>A</bold>): Representative images of immunohistochemical staining showing aneurysmal aortic leukocyte accumulation (macrophages, T cells and B cells). (<bold>B-E</bold>): Semi-quantification of aneurysmal aortic leukocyte accumulation. Aortic mural macrophage accumulation was scored from I to IV, while aortic CD4<sup>+</sup> T cells, CD8<sup>+</sup> T cells and B cells were quantified as positively stained cells number per aortic cross-section (ACS). Data are shown as media and interquartile (<bold>B</bold>) and mean and standard deviation (<bold>C&#8211;E</bold>). Non-parametric Mann-Whitney test (<bold>B</bold>) and Student's <italic toggle="yes">t</italic> test (<bold>C&#8211;E</bold>). <italic toggle="yes">N</italic>&#8201;=&#8201;10 for each group, *<italic toggle="yes">p&#8201;</italic>&lt;&#8201;0.05 and **<italic toggle="yes">p&#8201;</italic>&lt;&#8201;0.01 as compared to wild type (PIAS3<sup>+/+</sup>) mice.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fcvm-10-1092555-g002.jpg"/></fig></sec><sec id="s3e"><title>PIAS3 deficiency reduces aortic MMP2 and MMP9 expression</title><p>MMP2 and MMP9 are contributors of PPE-induced AAAs (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>). The levels of aortic MMP2 and MMP 9 were diminished in PIAS3<sup>&#8722;/&#8722;</sup> as compared to PIAS3<sup>+/+</sup> mice (<xref rid="F3" ref-type="fig">Figure&#160;3A</xref>). In semi-quantitative analysis, individual MMP positively stained areas were reduced by approximately 61% and 70% for MMP2 and MMP9, respectively, in PIAS3<sup>&#8722;/&#8722;</sup> as compared to PIAS3<sup>+/+</sup> mice (<xref rid="F3" ref-type="fig">Figures&#160;3B,C</xref>).</p><fig position="float" id="F3" orientation="portrait"><label>Figure 3</label><caption><p>PIAS3 deficiency decreases the expression levels of matrix metalloproteinases 2 and 9. (<bold>A</bold>): Representative immunohistochemical staining images of MMP2 and MMP9 in aneurysmal aortas from mild type (PIAS3<sup>+/+</sup>) and PIAS3 deficient (PIAS3<sup>&#8722;/&#8722;</sup>) mice. (<bold>B</bold>): Semi-quantification of MMP2 and MMP9 expression levels in aneurysmal lesions quantitated as the positively stained area per aortic cross-section. <italic toggle="yes">N</italic>&#8201;=&#8201;10 for each group, *<italic toggle="yes">p&#8201;</italic>&lt;&#8201;0.05 and **<italic toggle="yes">p&#8201;</italic>&lt;&#8201;0.01 as compared to PIAS3<sup>+/+</sup> mice.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fcvm-10-1092555-g003.jpg"/></fig></sec><sec id="s3f"><title>PIAS3 deficiency suppresses mural angiogenesis</title><p>Mural angiogenesis is involved in AAA pathogenesis (<xref rid="B24" ref-type="bibr">24</xref>&#8211;<xref rid="B27" ref-type="bibr">27</xref>). We thus determined whether the protective effect of PIAS3 deficiency on AAAs was associated with altered angiogenesis. In immunostaining of CD31, a maker of angiogenesis, the neovessels were significantly less in PIAS3<sup>&#8722;/&#8722;</sup> than that in PIAS3<sup>+/+</sup> mice (<xref rid="F4" ref-type="fig">Figure&#160;4</xref>, left panel), with a 40% reduction in mural neovessels in PIAS3<sup>&#8722;/&#8722;</sup> mice (<xref rid="F4" ref-type="fig">Figure&#160;4</xref>, right panel).</p><fig position="float" id="F4" orientation="portrait"><label>Figure 4</label><caption><p>PIAS3 deficiency inhibits mural angiogenesis. Aortic frozen sections were immunostained with an antibody against mouse CD31. Angiogenesis was quantitated as the number of CD31-positive neovessels per aortic cross-section (ACS). <italic toggle="yes">N</italic>&#8201;=&#8201;10 for each group, *<italic toggle="yes">p&#8201;</italic>&lt;&#8201;0.05 and **<italic toggle="yes">p&#8201;</italic>&lt;&#8201;0.01 as compared to wild type (PIAS3<sup>+/+</sup>) mice.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fcvm-10-1092555-g004.jpg"/></fig></sec></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><p>Inflammation is implicated in the initiation and evolution of AAAs (<xref rid="B28" ref-type="bibr">28</xref>). It leads to aortic medial elastin degradation, the apoptosis and dysfunction of vascular SMC by proteolytic enzymes, free radicals, cytokines, and other inflammatory products (<xref rid="B29" ref-type="bibr">29</xref>). JAK2/STAT3 signaling is a main intrinsic pathway for inflammation. It is involved in the creation and sustenance of inflammatory milieus by modulating the expression of cytokines, chemokines, and other mediators (<xref rid="B30" ref-type="bibr">30</xref>). In this study, we found that PIAS3 deficiency attenuated experimental AAAs induced by elastase infusion. There were less aneurysmal medial elastin and SMC destruction in PIAS3<sup>&#8722;/&#8722;</sup> mice than those in PIAS3<sup>+/+</sup> mice. Moreover, in comparison with PIAS3<sup>+/+</sup> mice, aortic leukocyte infiltration, MMP expression and mural angiogenesis were attenuated in PIAS3<sup>&#8722;/&#8722;</sup> mice. These results demonstrate that PIAS3 deletion ameliorated experimental AAAs by preserving SMCs, inhibiting aortic leukocyte infiltration, and decreasing angiogenesis.</p><p>It has been previously shown that JAK2/STAT3 signaling activity was involved in the pathogenesis of AAAs (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B32" ref-type="bibr">32</xref>). In human aortic tissues, JAK2/STAT3 expression levels were higher in aneurysmal than those in non-aneurysmal aortas (<xref rid="B31" ref-type="bibr">31</xref>). IL-6, a JAK2/STAT3 activator, was elevated in the human aneurysmal as compared to non-aneurysmal aortas (<xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B33" ref-type="bibr">33</xref>). However, previously reported influence of STAT3 pathway components on AAAs varied. Disruption of STAT3 signaling in bone marrow&#8211;derived cells aggravated whereas myeloid cell-STAT3 deletion had limited effect on experimental AAAs (<xref rid="B34" ref-type="bibr">34</xref>). A STAT3 inhibitor attenuated angiotensin II-induced AAA progression in mice through inhibiting vascular inflammation and maintaining autophagy (<xref rid="B35" ref-type="bibr">35</xref>), whereas severe angiotensin II-induced AAAs were noted in mice overexpressing SOCS3, another negative regulator of JAK2/STAT3 signaling, in T lymphocytes in association with impaired IL-17 production (<xref rid="B34" ref-type="bibr">34</xref>). These discrepancies of STAT3 inhibition/activation concerning AAA progression might be resulted from differential influence on different vascular structural and immune cells. In SMC, the STAT3 inhibitor suppressed inflammation related signaling activation, such as JAK2/STAT3 and NF-kB signaling, which ameliorated AAAs (<xref rid="B35" ref-type="bibr">35</xref>). In T cells, overexpression SOCS3 blocked STAT3 signaling activation, thereby significantly impeded Th17 development and decreased interleukin-17 production (<xref rid="B34" ref-type="bibr">34</xref>). Reduced IL-17 production is associated with severe vascular inflammation and enhanced susceptibility to aneurysms (<xref rid="B36" ref-type="bibr">36</xref>).</p><p>We previously found that PIAS3 was negatively associated with the JAK2/STAT3 activation and inflammatory responses in macrophages during atherosclerosis (<xref rid="B14" ref-type="bibr">14</xref>). Unexpectedly, the present study showed that PIAS3 deficiency attenuated PPE-induced AAA formation and reduced leukocyte infiltration in experimental AAA lesions. It is possible that chronic activation of STAT3 caused by PIAS3 deficiency may trigger tissue repair responses. In a recent study, SMC-specific SOCS3 deletion was protective against aortic dissection (<xref rid="B37" ref-type="bibr">37</xref>). Regionally activating STAT3 in the aorta may initiate host defense mechanisms thereby promoting SMC survival following vascular injury (<xref rid="B37" ref-type="bibr">37</xref>). Chronic activation of STAT3 evoked tissue repair responses by altering the phenotype of SMCs, macrophages, and fibroblasts, leading to enhancement of the tensile strength of the aortic wall (<xref rid="B37" ref-type="bibr">37</xref>). In addition, mural angiogenesis also contributes to AAA pathogenesis. In present study, PIAS3 deletion decreased aneurysmal mural angiogenesis, which might also result in the attenuation of AAA formation in PIAS3 deficient mice. PIAS3 has been shown to increase the levels of hypoxia-inducible factor (HIF)-1<italic toggle="yes">&#945;</italic>, a critical angiogenic transcription factor, by stabilizing HIF-1 protein (<xref rid="B38" ref-type="bibr">38</xref>). HIF-1<italic toggle="yes">&#945;</italic>/vascular endothelial growth factor (VEGF-A) pathway plays a vital role in the development of AAAs (<xref rid="B39" ref-type="bibr">39</xref>&#8211;<xref rid="B43" ref-type="bibr">43</xref>). Thus, angiogenesis inhibition by PIAS3 deficiency may be potentially attributed to low HIF-1 protein stability and thus reduced VEGF-A levels.</p><p>In conclusion, the present study demonstrated that genetic PIAS3 deficiency attenuated experimental AAAs in association with reduced medial elastin degradation, SMC depletion, leukocyte infiltration and aortic wall angiogenesis. Due to the limited aneurysmal tissues, the functions of MMPs and STAT3 were not determined in the present study. Further studies on the mechanism of PIAS3 regulating AAA will be conducted in the future.</p></sec></body><back><sec sec-type="data-availability" id="s5"><title>Data availability statement</title><p>The original contributions presented in the study are included in the article/<xref rid="s10" ref-type="sec"><bold>Supplementary materials</bold></xref>, further inquiries can be directed to the corresponding author/s.</p></sec><sec id="s6"><title>Ethics statement</title><p>The animal study was reviewed and approved by the Laboratory Animal Administration Committee of Xi'an Jiaotong University (No. 2019-1178).</p></sec><sec id="s7"><title>Author contributions</title><p>SZ, RW, BX and MM are involved in the study design; SZ, EL and RW collected and analyzed data, as well as drafted the manuscript; WF, HL, CX, PW, KT, QY, YL and RW performed experiments; EL, BX, RW and SZ critically revised manuscript. All authors contributed to the article and approved the submitted version.</p></sec><sec sec-type="COI-statement" id="s9"><title>Conflict of interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="disclaimer" id="s11"><title>Publisher's note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><sec sec-type="supplementary-material" id="s10"><title>Supplementary material</title><p>The Supplementary Material for this article can be found online at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.frontiersin.org/articles/10.3389/fcvm.2023.1092555/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fcvm.2023.1092555/full#supplementary-material</ext-link>.</p><supplementary-material id="SD1" position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Table1.docx" id="d95e864" position="anchor" orientation="portrait"/></supplementary-material></sec><ref-list><title>References</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>W</given-names></name><name name-style="western"><surname>Yao</surname><given-names>L</given-names></name><name name-style="western"><surname>Roetker</surname><given-names>NS</given-names></name><name name-style="western"><surname>Alonso</surname><given-names>A</given-names></name><name name-style="western"><surname>Lutsey</surname><given-names>PL</given-names></name><name name-style="western"><surname>Steenson</surname><given-names>CC</given-names></name><etal/></person-group><article-title>Lifetime risk and risk factors for abdominal aortic aneurysm in a 24-year prospective study: the aric study (atherosclerosis risk in communities)</article-title>. <source>Arterioscler, Thrombosis, and Vasc Biol.</source> (<year>2016</year>) <volume>36</volume>(<issue>12</issue>):<fpage>2468</fpage>&#8211;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1161/ATVBAHA.116.308147</pub-id><pub-id pub-id-type="pmcid">PMC5397388</pub-id><pub-id pub-id-type="pmid">27834688</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takada</surname><given-names>M</given-names></name><name name-style="western"><surname>Yamagishi</surname><given-names>K</given-names></name><name name-style="western"><surname>Tamakoshi</surname><given-names>A</given-names></name><name name-style="western"><surname>Iso</surname><given-names>H</given-names></name><name name-style="western"><surname>Group</surname><given-names>JS</given-names></name></person-group>. <article-title>Body mass Index and mortality from aortic aneurysm and dissection</article-title>. <source>J Atheroscler Thromb.</source> (<year>2021</year>) <volume>28</volume>(<issue>4</issue>):<fpage>338</fpage>&#8211;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.5551/jat.57232</pub-id><pub-id pub-id-type="pmid">32727971</pub-id><pub-id pub-id-type="pmcid">PMC8147012</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Juvonen</surname><given-names>J</given-names></name><name name-style="western"><surname>Surcel</surname><given-names>HM</given-names></name><name name-style="western"><surname>Satta</surname><given-names>J</given-names></name><name name-style="western"><surname>Teppo</surname><given-names>AM</given-names></name><name name-style="western"><surname>Bloigu</surname><given-names>A</given-names></name><name name-style="western"><surname>Syrjala</surname><given-names>H</given-names></name><etal/></person-group><article-title>Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm</article-title>. <source>Arterioscler, Thrombosis, and Vasc Biol.</source> (<year>1997</year>) <volume>17</volume>(<issue>11</issue>):<fpage>2843</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1161/01.atv.17.11.2843</pub-id><pub-id pub-id-type="pmid">9409264</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Batra</surname><given-names>R</given-names></name><name name-style="western"><surname>Suh</surname><given-names>MK</given-names></name><name name-style="western"><surname>Carson</surname><given-names>JS</given-names></name><name name-style="western"><surname>Dale</surname><given-names>MA</given-names></name><name name-style="western"><surname>Meisinger</surname><given-names>TM</given-names></name><name name-style="western"><surname>Fitzgerald</surname><given-names>M</given-names></name><etal/></person-group><article-title>Il-1beta (interleukin-1beta) and tnf-alpha (tumor necrosis factor-alpha) impact abdominal aortic aneurysm formation by differential effects on macrophage polarization</article-title>. <source>Arterioscler, Thrombosis, and Vasc Biol.</source> (<year>2018</year>) <volume>38</volume>(<issue>2</issue>):<fpage>457</fpage>&#8211;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1161/ATVBAHA.117.310333</pub-id><pub-id pub-id-type="pmcid">PMC7450719</pub-id><pub-id pub-id-type="pmid">29217508</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ouyang</surname><given-names>M</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name><name name-style="western"><surname>Yu</surname><given-names>B</given-names></name></person-group>. <article-title>Aberrant mitochondrial dynamics: an emerging pathogenic driver of abdominal aortic aneurysm</article-title>. <source>Cardiovasc Ther</source>. (<year>2021</year>) <volume>2021:6615400</volume>. <pub-id pub-id-type="doi">10.1155/2021/6615400</pub-id><pub-id pub-id-type="pmcid">PMC8221877</pub-id><pub-id pub-id-type="pmid">34221126</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiong</surname><given-names>W</given-names></name><name name-style="western"><surname>MacTaggart</surname><given-names>J</given-names></name><name name-style="western"><surname>Knispel</surname><given-names>R</given-names></name><name name-style="western"><surname>Worth</surname><given-names>J</given-names></name><name name-style="western"><surname>Persidsky</surname><given-names>Y</given-names></name><name name-style="western"><surname>Baxter</surname><given-names>BT</given-names></name></person-group>. <article-title>Blocking tnf-alpha attenuates aneurysm formation in a murine model</article-title>. <source>J Immunol.</source> (<year>2009</year>) <volume>183</volume>(<issue>4</issue>):<fpage>2741</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.0803164</pub-id><pub-id pub-id-type="pmid">19620291</pub-id><pub-id pub-id-type="pmcid">PMC4028114</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Isselbacher</surname><given-names>EM</given-names></name></person-group>. <article-title>Losartan for the treatment of marfan syndrome: hope fades</article-title>. <source>J Am Coll Cardiol.</source> (<year>2018</year>) <volume>72</volume>(<issue>14</issue>):<fpage>1619</fpage>&#8211;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2018.07.051</pub-id><pub-id pub-id-type="pmid">30261964</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>J</given-names></name><name name-style="western"><surname>Morimoto</surname><given-names>K</given-names></name><name name-style="western"><surname>Bao</surname><given-names>W</given-names></name><name name-style="western"><surname>Yu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Okita</surname><given-names>Y</given-names></name><name name-style="western"><surname>Okada</surname><given-names>K</given-names></name></person-group>. <article-title>Glucagon-Like peptide-1 prevented abdominal aortic aneurysm development in rats</article-title>. <source>Surgery Today.</source> (<year>2016</year>) <volume>46</volume>(<issue>9</issue>):<fpage>1099</fpage>&#8211;<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1007/s00595-015-1287-z</pub-id><pub-id pub-id-type="pmid">26658813</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Banerjee</surname><given-names>S</given-names></name><name name-style="western"><surname>Biehl</surname><given-names>A</given-names></name><name name-style="western"><surname>Gadina</surname><given-names>M</given-names></name><name name-style="western"><surname>Hasni</surname><given-names>S</given-names></name><name name-style="western"><surname>Schwartz</surname><given-names>DM</given-names></name></person-group>. <article-title>Jak-Stat signaling as a target for inflammatory and autoimmune diseases: current and future prospects</article-title>. <source>Drugs</source>. (<year>2017</year>) <volume>77</volume>(<issue>11</issue>):<fpage>1261</fpage>. <comment>(Vol 77, Pg 521, 2017)</comment><pub-id pub-id-type="doi">10.1007/s40265-017-0772-7</pub-id><pub-id pub-id-type="pmid">28255960</pub-id><pub-id pub-id-type="pmcid">PMC7102286</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O'Shea</surname><given-names>JJ</given-names></name></person-group>. <article-title>Targeting the jak/stat pathway for immunosuppression</article-title>. <source>Ann Rheum Dis</source>. (<year>2004</year>) <volume>63</volume>:<fpage>67</fpage>&#8211;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1136/ard.2004.028290</pub-id><pub-id pub-id-type="pmid">15479876</pub-id><pub-id pub-id-type="pmcid">PMC1766780</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garbers</surname><given-names>C</given-names></name><name name-style="western"><surname>Aparicio-Siegmund</surname><given-names>S</given-names></name><name name-style="western"><surname>Rose-John</surname><given-names>S</given-names></name></person-group>. <article-title>The il-6/Gp130/Stat3 signaling axis: recent advances towards specific inhibition</article-title>. <source>Curr Opin Immunol</source>. (<year>2015</year>) <volume>34</volume>:<fpage>75</fpage>&#8211;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/j.coi.2015.02.008</pub-id><pub-id pub-id-type="pmid">25749511</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kiu</surname><given-names>H</given-names></name><name name-style="western"><surname>Nicholson</surname><given-names>SE</given-names></name></person-group>. <article-title>Biology and significance of the jak/stat signalling pathways</article-title>. <source>Growth Factors.</source> (<year>2012</year>) <volume>30</volume>(<issue>2</issue>):<fpage>88</fpage>&#8211;<lpage>106</lpage>. <pub-id pub-id-type="doi">10.3109/08977194.2012.660936</pub-id><pub-id pub-id-type="pmid">22339650</pub-id><pub-id pub-id-type="pmcid">PMC3762697</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liao</surname><given-names>MF</given-names></name><name name-style="western"><surname>Xu</surname><given-names>J</given-names></name><name name-style="western"><surname>Clair</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Ehrman</surname><given-names>B</given-names></name><name name-style="western"><surname>Graham</surname><given-names>LM</given-names></name><name name-style="western"><surname>Eagleton</surname><given-names>MJ</given-names></name></person-group>. <article-title>Local and systemic alterations in signal transducers and activators of transcription (stat) associated with human abdominal aortic aneurysms</article-title>. <source>J Surg Res</source>. (<year>2012</year>) <volume>176</volume>(<issue>1</issue>):<fpage>321</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.jss.2011.05.041</pub-id><pub-id pub-id-type="pmid">21764069</pub-id><pub-id pub-id-type="pmcid">PMC3197955</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>R</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Xu</surname><given-names>LR</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>XF</given-names></name><name name-style="western"><surname>Bai</surname><given-names>L</given-names></name><etal/></person-group><article-title>Protein inhibitor of activated Stat3 suppresses oxidized ldl-induced cell responses during atherosclerosis in apolipoprotein E-deficient mice</article-title>. <source>Sci Rep-Uk.</source> (<year>2016</year>) <volume>6</volume>:<fpage>36790</fpage>. <pub-id pub-id-type="doi">10.1038/Srep36790</pub-id><pub-id pub-id-type="pmcid">PMC5109228</pub-id><pub-id pub-id-type="pmid">27845432</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Okazaki</surname><given-names>Y</given-names></name><name name-style="western"><surname>Furuno</surname><given-names>M</given-names></name><name name-style="western"><surname>Kasukawa</surname><given-names>T</given-names></name><name name-style="western"><surname>Adachi</surname><given-names>J</given-names></name><name name-style="western"><surname>Bono</surname><given-names>H</given-names></name><name name-style="western"><surname>Kondo</surname><given-names>S</given-names></name><etal/></person-group><article-title>Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cdnas</article-title>. <source>Nature.</source> (<year>2002</year>) <volume>420</volume>(<issue>6915</issue>):<fpage>563</fpage>&#8211;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1038/nature01266</pub-id><pub-id pub-id-type="pmid">12466851</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>HL</given-names></name><name name-style="western"><surname>Tian</surname><given-names>KL</given-names></name><name name-style="western"><surname>Xia</surname><given-names>CC</given-names></name><name name-style="western"><surname>Wei</surname><given-names>PP</given-names></name><name name-style="western"><surname>Xu</surname><given-names>BY</given-names></name><name name-style="western"><surname>Fu</surname><given-names>WL</given-names></name><etal/></person-group><article-title>Kunming Mouse strain is less susceptible to elastase-induced abdominal aortic aneurysms</article-title>. <source>Anim Model Exp Med</source>. (<year>2022</year>) <volume>5</volume>(<issue>1</issue>):<fpage>72</fpage>&#8211;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1002/ame2.12197</pub-id><pub-id pub-id-type="pmcid">PMC8879628</pub-id><pub-id pub-id-type="pmid">35229996</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>HL</given-names></name><name name-style="western"><surname>Wei</surname><given-names>PP</given-names></name><name name-style="western"><surname>Fu</surname><given-names>WL</given-names></name><name name-style="western"><surname>Xia</surname><given-names>CC</given-names></name><name name-style="western"><surname>Li</surname><given-names>YK</given-names></name><name name-style="western"><surname>Tian</surname><given-names>KL</given-names></name><etal/></person-group><article-title>Dapagliflozin ameliorates the formation and progression of experimental abdominal aortic aneurysms by reducing aortic inflammation in mice</article-title>. <source>Oxid Med Cell Longev</source>. (<year>2022</year>) 2022:<fpage>8502059</fpage>. <pub-id pub-id-type="doi">10.1155/2022/8502059</pub-id><pub-id pub-id-type="pmid">35126822</pub-id><pub-id pub-id-type="pmcid">PMC8816542</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tian</surname><given-names>KL</given-names></name><name name-style="western"><surname>Xia</surname><given-names>CC</given-names></name><name name-style="western"><surname>Liu</surname><given-names>HL</given-names></name><name name-style="western"><surname>Xu</surname><given-names>BY</given-names></name><name name-style="western"><surname>Wei</surname><given-names>PP</given-names></name><name name-style="western"><surname>Fu</surname><given-names>WL</given-names></name><etal/></person-group><article-title>Temporal and quantitative analysis of aortic immunopathologies in elastase-induced mouse abdominal aortic aneurysms</article-title>. <source>J Immunol Res</source>. (<year>2021</year>) 2021:<fpage>6297332</fpage>. <pub-id pub-id-type="doi">10.1155/2021/6297332</pub-id><pub-id pub-id-type="pmid">34825008</pub-id><pub-id pub-id-type="pmcid">PMC8610647</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>BH</given-names></name><name name-style="western"><surname>Iida</surname><given-names>Y</given-names></name><name name-style="western"><surname>Glover</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Ge</surname><given-names>YB</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xuan</surname><given-names>HJ</given-names></name><etal/></person-group><article-title>Inhibition of vegf (vascular endothelial growth factor)-a or its receptor activity suppresses experimental aneurysm progression in the aortic elastase infusion model</article-title>. <source>Arterioscl Throm Vas</source>. (<year>2019</year>) <volume>39</volume>(<issue>8</issue>):<fpage>1652</fpage>&#8211;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1161/Atvbaha.119.312497</pub-id><pub-id pub-id-type="pmcid">PMC6699755</pub-id><pub-id pub-id-type="pmid">31294623</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ikezoe</surname><given-names>T</given-names></name><name name-style="western"><surname>Shoji</surname><given-names>T</given-names></name><name name-style="western"><surname>Guo</surname><given-names>J</given-names></name><name name-style="western"><surname>Shen</surname><given-names>F</given-names></name><name name-style="western"><surname>Lu</surname><given-names>HS</given-names></name><name name-style="western"><surname>Daugherty</surname><given-names>A</given-names></name><etal/></person-group><article-title>No effect of hypercholesterolemia on elastase-induced experimental abdominal aortic aneurysm progression</article-title>. <source>Biomolecules.</source> (<year>2021</year>) <volume>11</volume>(<issue>10</issue>):1434&#8211;48. <pub-id pub-id-type="doi">10.3390/biom11101434</pub-id><pub-id pub-id-type="pmid">34680067</pub-id><pub-id pub-id-type="pmcid">PMC8533453</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>J</given-names></name><name name-style="western"><surname>Shoji</surname><given-names>T</given-names></name><name name-style="western"><surname>Ge</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>S</given-names></name><etal/></person-group><article-title>Treatment with the prolyl hydroxylase inhibitor jnj promotes abdominal aortic aneurysm progression in diabetic mice</article-title>. <source>Eur J Vasc Endovasc Surg.</source> (<year>2022</year>) <volume>63</volume>(<issue>3</issue>):<fpage>484</fpage>&#8211;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejvs.2021.10.030</pub-id><pub-id pub-id-type="pmid">34872812</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Longo</surname><given-names>GM</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>W</given-names></name><name name-style="western"><surname>Greiner</surname><given-names>TC</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Fiotti</surname><given-names>N</given-names></name><name name-style="western"><surname>Baxter</surname><given-names>BT</given-names></name></person-group>. <article-title>Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms</article-title>. <source>J Clin Investigation.</source> (<year>2002</year>) <volume>110</volume>(<issue>5</issue>):<fpage>625</fpage>&#8211;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1172/JCI15334</pub-id><pub-id pub-id-type="pmcid">PMC151106</pub-id><pub-id pub-id-type="pmid">12208863</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dhital</surname><given-names>S</given-names></name><name name-style="western"><surname>Vyavahare</surname><given-names>NR</given-names></name></person-group>. <article-title>Nanoparticle-Based targeted delivery of pentagalloyl glucose reverses elastase-induced abdominal aortic aneurysm and restores aorta to the healthy state in mice</article-title>. <source>PloS one.</source> (<year>2020</year>) <volume>15</volume>(<issue>3</issue>):<fpage>e0227165</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0227165</pub-id><pub-id pub-id-type="pmid">32218565</pub-id><pub-id pub-id-type="pmcid">PMC7100957</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>M</given-names></name><name name-style="western"><surname>Sui</surname><given-names>W</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>C</given-names></name><name name-style="western"><surname>Xue</surname><given-names>F</given-names></name><name name-style="western"><surname>Tian</surname><given-names>Z</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>J</given-names></name><etal/></person-group><article-title>Erythropoietin promotes abdominal aortic aneurysms in mice through angiogenesis and inflammatory infiltration</article-title>. <source>Science Translational Med.</source> (<year>2021</year>) <volume>13</volume>(<issue>603</issue>):eaaz4959. <pub-id pub-id-type="doi">10.1126/scitranslmed.aaz4959</pub-id><pub-id pub-id-type="pmid">34290056</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lukasiewicz</surname><given-names>A</given-names></name><name name-style="western"><surname>Reszec</surname><given-names>J</given-names></name><name name-style="western"><surname>Kowalewski</surname><given-names>R</given-names></name><name name-style="western"><surname>Chyczewski</surname><given-names>L</given-names></name><name name-style="western"><surname>Lebkowska</surname><given-names>U</given-names></name></person-group>. <article-title>Assessment of inflammatory infiltration and angiogenesis in the thrombus and the wall of abdominal aortic aneurysms on the basis of histological parameters and computed tomography angiography study</article-title>. <source>Folia Histochemica et Cytobiologica.</source> (<year>2012</year>) <volume>50</volume>(<issue>4</issue>):<fpage>547</fpage>&#8211;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.5603/20323</pub-id><pub-id pub-id-type="pmid">23264218</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Satta</surname><given-names>J</given-names></name><name name-style="western"><surname>Soini</surname><given-names>Y</given-names></name><name name-style="western"><surname>Mosorin</surname><given-names>M</given-names></name><name name-style="western"><surname>Juvonen</surname><given-names>T</given-names></name></person-group>. <article-title>Angiogenesis is associated with mononuclear inflammatory cells in abdominal aortic aneurysms</article-title>. <source>Ann Chir Gynaecol</source>. (<year>1998</year>) <volume>87</volume>(<issue>1</issue>):<fpage>40</fpage>&#8211;<lpage>2</lpage>.<pub-id pub-id-type="pmid">9598229</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thompson</surname><given-names>MM</given-names></name><name name-style="western"><surname>Jones</surname><given-names>L</given-names></name><name name-style="western"><surname>Nasim</surname><given-names>A</given-names></name><name name-style="western"><surname>Sayers</surname><given-names>RD</given-names></name><name name-style="western"><surname>Bell</surname><given-names>PR</given-names></name></person-group>. <article-title>Angiogenesis in abdominal aortic aneurysms</article-title>. <source>Eur J Vasc Endovasc Surg</source>. (<year>1996</year>) <volume>11</volume>(<issue>4</issue>):<fpage>464</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/s1078-5884(96)80183-3</pub-id><pub-id pub-id-type="pmid">8846184</pub-id></mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>J</given-names></name><name name-style="western"><surname>Guo</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name><name name-style="western"><surname>Xu</surname><given-names>B</given-names></name><name name-style="western"><surname>Miyata</surname><given-names>M</given-names></name></person-group>. <article-title>Importance of Nlrp3 inflammasome in abdominal aortic aneurysms</article-title>. <source>J Atheroscler Thromb.</source> (<year>2021</year>) <volume>28</volume>(<issue>5</issue>):<fpage>454</fpage>&#8211;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.5551/jat.RV17048</pub-id><pub-id pub-id-type="pmid">33678767</pub-id><pub-id pub-id-type="pmcid">PMC8193780</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Golledge</surname><given-names>J</given-names></name></person-group>. <article-title>Abdominal aortic aneurysm: update on pathogenesis and medical treatments</article-title>. <source>Nat Rev Cardiol.</source> (<year>2019</year>) <volume>16</volume>(<issue>4</issue>):<fpage>225</fpage>&#8211;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1038/s41569-018-0114-9</pub-id><pub-id pub-id-type="pmid">30443031</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hillmer</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>HY</given-names></name><name name-style="western"><surname>Li</surname><given-names>HS</given-names></name><name name-style="western"><surname>Watowich</surname><given-names>SS</given-names></name></person-group>. <article-title>Stat3 signaling in immunity</article-title>. <source>Cytokine Growth F R</source>. (<year>2016</year>) <volume>31</volume>:<fpage>1</fpage>&#8211;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1016/j.cytogfr.2016.05.001</pub-id><pub-id pub-id-type="pmcid">PMC5050093</pub-id><pub-id pub-id-type="pmid">27185365</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiao</surname><given-names>J</given-names></name><name name-style="western"><surname>Wei</surname><given-names>ZJ</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><name name-style="western"><surname>Chen</surname><given-names>WQ</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Yang</surname><given-names>CL</given-names></name><etal/></person-group><article-title>Experimental abdominal aortic aneurysm growth is inhibited by blocking the Jak2/Stat3 pathway</article-title>. <source>Int J Cardiol</source>. (<year>2020</year>) <volume>312</volume>:<fpage>100</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijcard.2020.03.072</pub-id><pub-id pub-id-type="pmid">32334849</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lindeman</surname><given-names>JH</given-names></name><name name-style="western"><surname>Abdul-Hussien</surname><given-names>H</given-names></name><name name-style="western"><surname>Schaapherder</surname><given-names>AF</given-names></name><name name-style="western"><surname>Van Bockel</surname><given-names>JH</given-names></name><name name-style="western"><surname>Von der Thusen</surname><given-names>JH</given-names></name><name name-style="western"><surname>Roelen</surname><given-names>DL</given-names></name><etal/></person-group><article-title>Enhanced expression and activation of pro-inflammatory transcription factors distinguish aneurysmal from atherosclerotic aorta: il-6- and il-8-dominated inflammatory responses prevail in the human aneurysm</article-title>. <source>Clinical Science.</source> (<year>2008</year>) <volume>114</volume>(<issue>11</issue>):<fpage>687</fpage>&#8211;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1042/CS20070352</pub-id><pub-id pub-id-type="pmid">18078385</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harrison</surname><given-names>SC</given-names></name><name name-style="western"><surname>Smith</surname><given-names>AJP</given-names></name><name name-style="western"><surname>Jones</surname><given-names>GT</given-names></name><name name-style="western"><surname>Swerdlow</surname><given-names>DI</given-names></name><name name-style="western"><surname>Rampuri</surname><given-names>R</given-names></name><name name-style="western"><surname>Bown</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Interleukin-6 receptor pathways in abdominal aortic aneurysm</article-title>. <source>Eur Heart J</source>. (<year>2013</year>) <volume>34</volume>(<issue>48</issue>):<fpage>3707</fpage>&#8211;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehs354</pub-id><pub-id pub-id-type="pmid">23111417</pub-id><pub-id pub-id-type="pmcid">PMC3869968</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Romain</surname><given-names>M</given-names></name><name name-style="western"><surname>Taleb</surname><given-names>S</given-names></name><name name-style="western"><surname>Dalloz</surname><given-names>M</given-names></name><name name-style="western"><surname>Ponnuswamy</surname><given-names>P</given-names></name><name name-style="western"><surname>Esposito</surname><given-names>B</given-names></name><name name-style="western"><surname>Perez</surname><given-names>N</given-names></name><etal/></person-group><article-title>Overexpression of Socs3 in T lymphocytes leads to impaired interleukin-17 production and severe aortic aneurysm formation in mice&#8211;brief report</article-title>. <source>Arteriosclerosis, Thrombosis, and Vasc Biol.</source> (<year>2013</year>) <volume>33</volume>(<issue>3</issue>):<fpage>581</fpage>&#8211;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1161/ATVBAHA.112.300516</pub-id><pub-id pub-id-type="pmid">23329138</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>QY</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>YZ</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>JM</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>XM</given-names></name><etal/></person-group><article-title>A novel Stat3 inhibitor attenuates angiotensin ii-induced abdominal aortic aneurysm progression in mice through modulating vascular inflammation and autophagy</article-title>. <source>Cell Death Dis</source> (<year>2020</year>) <volume>11</volume>(<issue>2</issue>):<fpage>131</fpage>. <pub-id pub-id-type="doi">10.1038/s41419-020-2326-2</pub-id><pub-id pub-id-type="pmid">32071300</pub-id><pub-id pub-id-type="pmcid">PMC7028955</pub-id></mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chandesris</surname><given-names>MO</given-names></name><name name-style="western"><surname>Azarine</surname><given-names>A</given-names></name><name name-style="western"><surname>Ong</surname><given-names>KT</given-names></name><name name-style="western"><surname>Taleb</surname><given-names>S</given-names></name><name name-style="western"><surname>Boutouyrie</surname><given-names>P</given-names></name><name name-style="western"><surname>Mousseaux</surname><given-names>E</given-names></name><etal/></person-group><article-title>Frequent and widespread vascular abnormalities in human signal transducer and activator of transcription 3 deficiency</article-title>. <source>Circ Cardiovasc Genet.</source> (<year>2012</year>) <volume>5</volume>(<issue>1</issue>):<fpage>25</fpage>&#8211;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCGENETICS.111.961235</pub-id><pub-id pub-id-type="pmid">22084479</pub-id></mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hirakata</surname><given-names>S</given-names></name><name name-style="western"><surname>Aoki</surname><given-names>H</given-names></name><name name-style="western"><surname>Ohno-Urabe</surname><given-names>S</given-names></name><name name-style="western"><surname>Nishihara</surname><given-names>M</given-names></name><name name-style="western"><surname>Furusho</surname><given-names>A</given-names></name><name name-style="western"><surname>Nishida</surname><given-names>N</given-names></name><etal/></person-group><article-title>Genetic deletion of Socs3 in smooth muscle cells ameliorates aortic dissection in mice</article-title>. <source>Jacc-Basic Transl Sc</source>. (<year>2020</year>) <volume>5</volume>(<issue>2</issue>):<fpage>126</fpage>&#8211;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacbts.2019.10.010</pub-id><pub-id pub-id-type="pmid">32140621</pub-id><pub-id pub-id-type="pmcid">PMC7046542</pub-id></mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakagawa</surname><given-names>K</given-names></name><name name-style="western"><surname>Kohara</surname><given-names>T</given-names></name><name name-style="western"><surname>Uehata</surname><given-names>Y</given-names></name><name name-style="western"><surname>Miyakawa</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sato-Ueshima</surname><given-names>M</given-names></name><name name-style="western"><surname>Okubo</surname><given-names>N</given-names></name><etal/></person-group><article-title>Pias3 enhances the transcriptional activity of hif-1alpha by increasing its protein stability</article-title>. <source>Biochem Biophys Res Commun.</source> (<year>2016</year>) <volume>469</volume>(<issue>3</issue>):<fpage>470</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2015.12.047</pub-id><pub-id pub-id-type="pmid">26697750</pub-id></mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>B</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Song</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xie</surname><given-names>G</given-names></name><name name-style="western"><surname>Jiao</surname><given-names>S</given-names></name><name name-style="western"><surname>Shi</surname><given-names>L</given-names></name><etal/></person-group><article-title>The role of hypoxia-inducible factors in cardiovascular diseases</article-title>. <source>Pharmacol Ther.</source> (<year>2022</year>) <volume>238</volume>:<fpage>108186</fpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2022.108186</pub-id><pub-id pub-id-type="pmid">35413308</pub-id></mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaneko</surname><given-names>H</given-names></name><name name-style="western"><surname>Anzai</surname><given-names>T</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>T</given-names></name><name name-style="western"><surname>Kohno</surname><given-names>T</given-names></name><name name-style="western"><surname>Shimoda</surname><given-names>M</given-names></name><name name-style="western"><surname>Sasaki</surname><given-names>A</given-names></name><etal/></person-group><article-title>Role of vascular endothelial growth factor-a in development of abdominal aortic aneurysm</article-title>. <source>Cardiovasc Res.</source> (<year>2011</year>) <volume>91</volume>(<issue>2</issue>):<fpage>358</fpage>&#8211;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/cvr080</pub-id><pub-id pub-id-type="pmid">21436157</pub-id></mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name><name name-style="western"><surname>Xu</surname><given-names>B</given-names></name><name name-style="western"><surname>Xuan</surname><given-names>H</given-names></name><name name-style="western"><surname>Ge</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><etal/></person-group><article-title>Hypoxia-Inducible factor 1 in clinical and experimental aortic aneurysm disease</article-title>. <source>J Vasc Surg</source>. (<year>2018</year>) <volume>68</volume>(<issue>5</issue>):<fpage>1538</fpage>&#8211;<lpage>50; e2</lpage>. <pub-id pub-id-type="doi">10.1016/j.jvs.2017.09.030</pub-id><pub-id pub-id-type="pmid">29242064</pub-id><pub-id pub-id-type="pmcid">PMC5995616</pub-id></mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tedesco</surname><given-names>MM</given-names></name><name name-style="western"><surname>Terashima</surname><given-names>M</given-names></name><name name-style="western"><surname>Blankenberg</surname><given-names>FG</given-names></name><name name-style="western"><surname>Levashova</surname><given-names>Z</given-names></name><name name-style="western"><surname>Spin</surname><given-names>JM</given-names></name><name name-style="western"><surname>Backer</surname><given-names>MV</given-names></name><etal/></person-group><article-title>Analysis of in situ and ex vivo vascular endothelial growth factor receptor expression during experimental aortic aneurysm progression</article-title>. <source>Arterioscler, Thromb, Vasc Biol</source>. (<year>2009</year>) <volume>29</volume>(<issue>10</issue>):<fpage>1452</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1161/ATVBAHA.109.187757</pub-id><pub-id pub-id-type="pmid">19574559</pub-id><pub-id pub-id-type="pmcid">PMC2752726</pub-id></mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nishibe</surname><given-names>T</given-names></name><name name-style="western"><surname>Dardik</surname><given-names>A</given-names></name><name name-style="western"><surname>Kondo</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kudo</surname><given-names>F</given-names></name><name name-style="western"><surname>Muto</surname><given-names>A</given-names></name><name name-style="western"><surname>Nishi</surname><given-names>M</given-names></name><etal/></person-group><article-title>Expression and localization of vascular endothelial growth factor in normal abdominal aorta and abdominal aortic aneurysm</article-title>. <source>Int Angiol</source>. (<year>2010</year>) <volume>29</volume>(<issue>3</issue>):<fpage>260</fpage>&#8211;<lpage>5</lpage>.<pub-id pub-id-type="pmid">20502414</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>